Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
about
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasiaBone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cellsHereditary haemorrhagic telangiectasia: a clinical and scientific reviewHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseBone morphogenetic protein-9 is a circulating vascular quiescence factorNew insights into the pathogenesis and treatment of primary pulmonary hypertensionGenetic epidemiology: systemic sclerosis.Targeting BMP signalling in cardiovascular disease and anaemiaPathobiology of pulmonary arterial hypertension and right ventricular failureImmune and inflammatory mechanisms in pulmonary arterial hypertensionMolecular mechanisms of pulmonary arterial remodelingThe genetics of pulmonary arterial hypertensionPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesisAdams-Oliver syndrome: Additions to the clinical features and possible role of BMP pathwayLinking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertensionMutations of NOTCH3 in childhood pulmonary arterial hypertensionMutation study of Spanish patients with hereditary hemorrhagic telangiectasiaRecent trends in pulmonary arterial hypertensionGenotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.Pulmonary hypertension: diagnosis and managementOverexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertensionPulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USAFuture breakthroughs in the genetics of pulmonary arterial hypertension.Direct haemodynamic effects of pulmonary arteriovenous malformation embolisationHeritable forms of pulmonary arterial hypertension.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Genetics of pulmonary hypertensionAbsence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.PDGF signaling in pulmonary arterial hypertension.Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertensionTransforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertensionPharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsPulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene.Regression of pulmonary artery hypertension due to development of a pulmonary arteriovenous malformation.Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.
P2860
Q24302138-17C07634-5EF0-45E1-9262-E5362A3F0802Q24315838-5D5F84D7-0229-4340-A163-E24804CE3885Q24600839-4DCEAEA1-DEC7-4BEA-B1E0-01E2867C6803Q24645017-F281013C-ABF2-4434-8F0F-7D90D89E4824Q24657942-C9CF7A42-AA24-426E-9177-F846E0599970Q24679149-2B2570D2-FB87-4DB3-A4E4-49B80147B568Q24806161-48423B2A-FC59-41BD-B03A-DE1A13F7B4D0Q26783734-6F1EAE20-98CF-4630-B9E8-656891D3380EQ26821779-F107A14D-C74B-405A-88F4-0B5D2DBA07D6Q26851508-E9C0DCB2-9795-49DB-8A67-DEE3690E159AQ26991806-7306D312-4AF2-4718-8B85-984A11206276Q27027507-08C9F03D-16CA-4DB3-A580-5423A62F4FC1Q27687091-8E926CD8-1199-43B7-B607-70F4A8760307Q28236856-49B529AD-2B4F-432B-9A49-FD826E2E9B22Q28252125-D4162DB6-1F59-4004-8ED2-2810CE88F12CQ28361811-23A6D5B9-1D84-43AC-8B11-B306EBC48D7FQ28387429-97740556-88BB-4322-A649-C68C625CB41CQ30371147-F0C27AD4-D027-4844-8E5C-FCCFABE4CD60Q30475192-56B12D32-69C3-4B62-AADF-B37BF1EC3A16Q31092753-D2EE16D3-1853-4B0B-8D71-B3F77CBDB7BAQ33157071-6C0C9B2E-A09C-40C6-9712-A7983EED1E27Q33265315-7C11019E-1508-4DA6-9A5A-431BA074E4ABQ33580827-869F6484-78A4-434B-8106-9CBC38D01A04Q33788468-363A5B94-DC4E-4E8C-9AAA-CB6AE6E3E118Q33806126-376C737B-561B-473B-BCB1-461CE40A1636Q33906054-588EF94F-79DD-4901-87DD-7F555E7FBF4AQ33915567-5484F052-4FCD-4556-96CA-8BBA4169FF1EQ33965825-A7FA12E3-ECB6-4E7A-A78C-057B9AB9DF8AQ33965854-C624E34A-EC90-4B06-9999-DF5605B51CC8Q33968765-50FFB90B-B368-48CA-88D2-013E998CF3B7Q34048526-F9667E2B-BE04-40BA-AACC-428B82294671Q34250971-6D661589-32C7-4725-A4DA-22665CC3C109Q34271256-16D7EAA8-247F-4344-8F15-CA0135956101Q34326955-C6DE6257-836C-4467-8D8C-0F83AE27C29EQ34339756-8DF2D91B-3222-4FB1-A1BB-4122E25D9E69Q34344390-57DF790C-12D2-440E-9707-1851D241076DQ34414793-F3D2C083-043A-4A4C-A164-26DDD8DBCDD9Q34467052-969CE632-A298-4BE4-A7DC-61DF361EF765Q34467523-3E80D47B-F047-4467-975A-3270AB17A66AQ34535086-E2ED2888-58E2-4FB5-AA8E-6DD7A1DC19D2
P2860
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@ast
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@en
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@nl
type
label
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@ast
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@en
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@nl
prefLabel
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@ast
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@en
Clinical and molecular genetic ...... ry hemorrhagic telangiectasia.
@nl
P2093
P50
P1476
Clinical and molecular genetic ...... ary hemorrhagic telangiectasia
@en
P2093
Atkinson C
Nichols WC
Pauciulo M
Simonneau G
Thomson JR
P304
P356
10.1056/NEJM200108023450503
P407
P50
P577
2001-08-01T00:00:00Z